Singh, K., Railton, C., Hotchkiss, K., Herndon, J., Peters, K., Friedman, H., … Khasraw, M. (2023). A RANDOMIZED WINDOW OF OPPORTUNITY TRIAL WITH DOSE ESCALATION TO EVALUATE FLUOXETINE AND TEMOZOLOMIDE IN GLIOMA. In NEURO-ONCOLOGY (Vol. 25).

Singh, Kirit, Chelsea Railton, Kelly Hotchkiss, James Herndon, Katherine Peters, Henry Friedman, Annick Desjardins, et al. “A RANDOMIZED WINDOW OF OPPORTUNITY TRIAL WITH DOSE ESCALATION TO EVALUATE FLUOXETINE AND TEMOZOLOMIDE IN GLIOMA.” In NEURO-ONCOLOGY, Vol. 25, 2023.

Singh K, Railton C, Hotchkiss K, Herndon J, Peters K, Friedman H, et al. A RANDOMIZED WINDOW OF OPPORTUNITY TRIAL WITH DOSE ESCALATION TO EVALUATE FLUOXETINE AND TEMOZOLOMIDE IN GLIOMA. In: NEURO-ONCOLOGY. 2023.

Singh, Kirit, et al. “A RANDOMIZED WINDOW OF OPPORTUNITY TRIAL WITH DOSE ESCALATION TO EVALUATE FLUOXETINE AND TEMOZOLOMIDE IN GLIOMA.” NEURO-ONCOLOGY, vol. 25, 2023.

Singh K, Railton C, Hotchkiss K, Herndon J, Peters K, Friedman H, Desjardins A, Ashley D, Johnson MO, Patel A, Friedman A, Lim M, Fecci P, Piccioni D, McGranahan T, Nagpal S, Sulman E, Mischel P, Khasraw M. A RANDOMIZED WINDOW OF OPPORTUNITY TRIAL WITH DOSE ESCALATION TO EVALUATE FLUOXETINE AND TEMOZOLOMIDE IN GLIOMA. NEURO-ONCOLOGY. 2023.